Nov 13 (Reuters) - Instruments maker Thermo Fisher Scientific Inc has approached genetic testing specialist Qiagen NV about a potential deal, Bloomberg https://www.bloomberg.com/news/articles/2019-11-13/thermo-fisher-said-to-weigh-p u r c h a s e - o f - d i a g n o s t i c s - f i r m - q i a g e n reported on Wednesday, citing people with knowledge of the matter.
Thermo Fisher and Qiagen did not immediately respond to Reuters request for comment.
Germany's Qiagen, valued at about $8 billion as of Wednesday's close, has suffered a recent slump in performance and the stock was hit hard when its Chief Executive Officer Peer Schatz quit after a disappointing third-quarter forecast.
Qiagen shares closed up 10% at $35.60 on Wednesday, while Thermo Fisher shares closed up 1%. (Reporting by Shariq Khan in Bengaluru; Editing by Arun Koyyur)